Shattuck Labs (STTK)
(Real Time Quote from BATS)
$3.71 USD
+0.01 (0.27%)
Updated Sep 20, 2024 11:26 AM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
STTK 3.71 +0.01(0.27%)
Will STTK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for STTK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STTK
Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Tops Revenue Estimates
Kymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?
STTK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
What Makes Shattuck Labs (STTK) a New Buy Stock
Other News for STTK
Shattuck Labs Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Shattuck Labs’s SL-172154: A Novel CD47 Therapy Overcoming Previous Challenges with Promising Clinical Prospects
Shattuck Labs price target lowered by $1 at Citi, here's why
Shattuck Labs GAAP EPS of -$0.42, revenue of $1.61M
Assessing Shattuck Labs: Insights From 7 Financial Analysts